Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 USD | -1.55% | -3.85% | +52.17% |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company appears to be poorly valued given its net asset value.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.96 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.69 times its current sales, is high.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+52.17% | 1.02B | - | ||
+14.02% | 64.66B | A- | ||
-3.80% | 46.08B | A- | ||
+13.26% | 39.72B | B+ | ||
+19.28% | 25.82B | A- | ||
+8.22% | 18.8B | C+ | ||
-1.13% | 17.14B | B+ | ||
-21.03% | 15.86B | A- | ||
+1.06% | 15.05B | B+ | ||
-16.73% | 14.14B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PRM Stock
- Ratings Perimeter Solutions, SA